3M Company v. Starsiak

CourtDistrict Court, D. Minnesota
DecidedJune 26, 2020
Docket0:20-cv-01314
StatusUnknown

This text of 3M Company v. Starsiak (3M Company v. Starsiak) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
3M Company v. Starsiak, (mnd 2020).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

3M Company, Case No. 20-cv-1314 (SRN/TNL)

Plaintiff, ORDER ON PLAINTIFF’S v. MOTION FOR A TRO Matthew Starsiak, et al.,

Defendants.

John Ursu, David Gomez, Isaac B. Hall, Kerry L. Bundy, Michael M. Sawers, and Peter Routhier, Faegre Drinker Biddle & Reath, LLP, 2200 Wells Fargo Center, 90 S. 7th St., Minneapolis, MN 55402, and Peter W. Baldwin, Faegre Drinker Biddle & Reath, LLP, 1177 Avenue of the Americas, Ste. 41st Floor, New York, NY 10036, for Plaintiff

Timothy Schupp and Robert William Vaccaro, Meagher & Geer, PLLP, 33 S. 6th St., Ste. 4400, Minneapolis, MN 55402, for Defendants

SUSAN RICHARD NELSON, United States District Judge This matter is before the Court on the Motion for a Temporary Restraining Order (“TRO”) and Preliminary Injunction [Doc. No. 8] filed by Plaintiff 3M Company (“3M”). The parties appeared for a hearing by teleconference on June 25, 2020 before the undersigned judge. For the reasons set forth below, the Court grants Plaintiff’s request for a TRO, and defers ruling on its request for a preliminary injunction. I. BACKGROUND A. Procedural Background

On June 5, 2020 Plaintiff filed this trademark infringement lawsuit against Defendants Matthew Starsiak, AMK Energy Services LLC, and John Does 1 through 10. Plaintiff alleges that Defendants have falsely claimed to represent 3M, and have used 3M’s name and trademarks without authorization in a false and deceptive scheme to sell 3M N95 respirators to unwitting customers and consumers during the global COVID-19 pandemic. (Compl. [Doc. No. 1] ⁋ 1.) As a result, Plaintiff asserts that Defendants have violated

multiple provisions of the Lanham Act, as well as Minnesota state law regarding unlawful trade practices, trademark infringement, trademark dilution, and false advertising. (Id. ⁋⁋ 70–139.) On June 22, 2020, Plaintiff filed the instant motion for a TRO, seeking to enjoin Defendants from using 3M marks, and any other confusingly similar word, name or

symbol, in connection with the sale of goods or services, including 3M-brand N-95 respirators. (See Pl.’s Mem. [Doc. No. 10].) They further seek to enjoin Defendants from engaging in any false, misleading, or deceptive conduct in connection with 3M and its products, including representing themselves as an authorized distributor, vendor, agent, representative, retailer, and/or licensee of 3M or any of 3M’s products; falsely representing

to be associated or affiliated with or sponsored by 3M or any of 3M’s products; and falsely representing that 3M has increased the prices of its 3M-brand N95 respirators. (Id.) Along with their motion, memorandum, and reply memorandum [Doc. No. 35], 3M filed the Declaration of David A. Crist [Doc. No. 11], the Declaration of Charles Stobbie [Doc. No. 12], the Declaration of Haley Schaffer [Doc. No. 13], the Declaration of Ivan Fong [Doc. No. 14], the Declaration of John Ursu [Doc. No. 15], the Declaration of Matthew Hise

[Doc. No. 16], the Supplemental Declaration of Haley Schaffer [Doc. No. 36], and supporting exhibits. Separately, on June 24, 2020, Defendants filed a Motion to Dismiss pursuant to Federal Rule of Civil Procedure 12(b)(2) [Doc. No. 27], for lack of specific personal jurisdiction. The hearing on Defendants’ motion is scheduled for August 5, 2020. (Notice of Hr’g [Doc. No. 28].)

In opposition to Plaintiff’s TRO motion, Defendants also argue that the Court lacks specific personal jurisdiction over them, and accordingly a TRO cannot issue. (See Defs.’ Opp’n [Doc. No. 33] at 2.) In addition, Defendants argue that 3M does not satisfy the elements necessary for injunctive relief. (Id. at 2–6.) Plaintiff responds that the Court has specific personal jurisdiction1 over Defendants pursuant to the Calder “effects test,” set

forth in Calder v. Jones, 465 U.S. 783, 790 (1984). (Pl.’s Reply at 2–4.) B. Factual Background 3M is a Delaware corporation, with its principal place of business in St. Paul, Minnesota. (Compl. ⁋ 19.) It is a provider of personal protective equipment (“PPE”) for healthcare professionals, industry workers, and the public. (Stobbie Decl. ⁋ 4.) In

particular, it is a leading manufacturer of N95 respirators, which have been sold under the

1 Plaintiff does not assert that the Court has general personal jurisdiction over Defendants. 3M brand name for many years. (/d.; Crist Decl. P 10.) During the global COVID-19 pandemic, the general public has become familiar with 3M as a manufacturer of N95 respirators. (Crist Decl. P 16; Stobbie Decl. PP 14.) 3M contends that it has invested hundreds of millions of dollars in advertising and promoting its 3M-brand products to consumers, using the standard-character mark “3M” and the 3M design mark (together, the “3M Marks”). (Crist Decl. P 10.) 3M has obtained numerous federal trademark registrations for the 3M Marks. (/d., Exs. 5, 7.) Since the outbreak of COVID-19, 3M has increased its production of 3M-brand respirators to ensure that an adequate supply is available to governments and healthcare personnel, as well as to workers in the food, energy, and pharmaceutical industries. (Stobbie Decl. PP 8, 9, Exs. 1-3.) In the United States alone, 3M plans to produce 50 million respirators per month in June 2020. (/d. P 11, Exs. 1, 3.) More than 90 percent of 3M’s respirators are slated for healthcare and public health users. (d.) The Federal Emergency Management Agency is coordinating the distribution of these respirators in the United States, basing its allocation decisions on the most urgent needs. (/d. P 13.) Despite the heightened demand and need for PPE at this time, 3M has pledged to not increase prices of its N95 respirators in authorized sales, and will work to eliminate fraud and price- gouging by third parties in the midst of this public health crisis. (Stobbie Decl. P 12, Ex. 3, see also id. PP 14-16, Exs. 4, 5.) It believes that these efforts will protect the public from defective or inferior products and grossly inflated pricing. (/d.) Defendant Matthew Starsiak is a resident of Bountiful, Utah. (Compl. P 20.) He is the president of Defendant AMK Energy Services, LLC (“AMK Energy”). (Uid.) AMK

Energy is a Utah limited liability company, with a Bountiful, Utah address listed with the Utah Secretary of State. (Id. ⁋ 21.) Plaintiff also alleges that John Does 1 through 10

worked in concert with Defendants in connection with their fraudulent scheme. (Id. ⁋ 22.) On May 1, 2020, a prospective buyer of a billion 3M N95 respirators contacted the Paris office of the international law firm Dentons. (Schaffer Decl. ⁋ 13, Ex. 2.) The buyer stated that AMK Energy’s operations chief Mark Wright had advised him to correspond with Dentons about the possible purchase of 3M respirators. (Id.) In addition, the buyer attached a letter of intent for 3M, “via AmkGOV . . . which is providing access to 3M . . .

.” (Id.) Plaintiff alleges that the purchase of one billion respirators would account for roughly a year’s worth of 3M’s current total production of all models of N95 respirators. (Compl. ⁋ 68.) It further alleges that Defendants had no ability to “provide access to 3M.” (Id.) Moreover, 3M was unaware of any circumstances by which Defendants could legitimately offer to provide “access to 3M.” (Schaffer Decl. ⁋ 14.)

On May 10, 2020, Ivan Fong, 3M’s Senior Vice President, General Counsel & Secretary, and a Minnesota resident, received an email from Eric S. Schuster, an attorney at Funk & Bolton, PA. (Fong Decl. ⁋⁋ 1–3.) Schuster requested “10 minutes” of Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Johnson v. Arden
614 F.3d 785 (Eighth Circuit, 2010)
K-V Pharmaceutical Co. v. J. Uriach & CIA, S.A.
648 F.3d 588 (Eighth Circuit, 2011)
Dataphase Systems, Inc. v. C L Systems, Inc.
640 F.2d 109 (Eighth Circuit, 1981)
B & B HARDWARE, INC. v. Hargis Industries, Inc.
569 F.3d 383 (Eighth Circuit, 2009)
Fair Isaac Corp. v. Experian Information Solutions Inc.
645 F. Supp. 2d 734 (D. Minnesota, 2009)
Zumbro, Inc. v. California Natural Products
861 F. Supp. 773 (D. Minnesota, 1994)
Fair Isaac Corp. v. Experian Information Solutions Inc.
711 F. Supp. 2d 991 (D. Minnesota, 2010)
Hubbard Feeds, Inc. v. Animal Feed Supplement, Inc.
182 F.3d 598 (Eighth Circuit, 1999)
Paisley Park Enters., Inc. v. Boxill
361 F. Supp. 3d 869 (D. Maine, 2019)
Roederer v. J. Garcia Carrión, S.A.
732 F. Supp. 2d 836 (D. Minnesota, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
3M Company v. Starsiak, Counsel Stack Legal Research, https://law.counselstack.com/opinion/3m-company-v-starsiak-mnd-2020.